AP424A - Piperidine derivatives, their preparation and their application in therapy. - Google Patents

Piperidine derivatives, their preparation and their application in therapy. Download PDF

Info

Publication number
AP424A
AP424A APAP/P/1993/000575A AP9300575A AP424A AP 424 A AP424 A AP 424A AP 9300575 A AP9300575 A AP 9300575A AP 424 A AP424 A AP 424A
Authority
AP
ARIPO
Prior art keywords
group
compound
compounds
alkyl
hydrogen atom
Prior art date
Application number
APAP/P/1993/000575A
Other languages
English (en)
Other versions
AP9300575A0 (en
Inventor
Samir Jegham
Itzchak Angel
Johannes Schoemaker
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AP9300575A0 publication Critical patent/AP9300575A0/xx
Application granted granted Critical
Publication of AP424A publication Critical patent/AP424A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1993/000575A 1992-09-28 1993-09-27 Piperidine derivatives, their preparation and their application in therapy. AP424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211551A FR2696177B1 (fr) 1992-09-28 1992-09-28 Dérivés de pipéridine, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
AP9300575A0 AP9300575A0 (en) 1993-10-31
AP424A true AP424A (en) 1995-11-04

Family

ID=9433967

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000575A AP424A (en) 1992-09-28 1993-09-27 Piperidine derivatives, their preparation and their application in therapy.

Country Status (24)

Country Link
US (1) US5434169A (hu)
EP (1) EP0591027A1 (hu)
JP (1) JPH06211838A (hu)
KR (1) KR940007020A (hu)
CN (1) CN1087339A (hu)
AP (1) AP424A (hu)
AU (1) AU658533B2 (hu)
CA (1) CA2107061A1 (hu)
CZ (1) CZ282080B6 (hu)
DZ (1) DZ1718A1 (hu)
FI (1) FI934221A (hu)
FR (1) FR2696177B1 (hu)
HU (2) HUT65303A (hu)
IL (1) IL107133A (hu)
MA (1) MA22981A1 (hu)
MX (1) MX9305932A (hu)
NO (1) NO933435L (hu)
NZ (1) NZ248776A (hu)
OA (1) OA09840A (hu)
PL (1) PL172860B1 (hu)
SK (1) SK103193A3 (hu)
TN (1) TNSN93107A1 (hu)
TW (1) TW272190B (hu)
ZA (1) ZA937156B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191106T3 (es) * 1995-09-18 2003-09-01 Glaxo Group Ltd Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor.
EP0918518A4 (en) * 1996-04-19 2002-05-02 Univ California TREATMENT OF MIND AND MOOD DISEASES WITH GLUTAMATERGIC MODULATORS.
FR2765221B1 (fr) * 1997-06-25 1999-07-30 Synthelabo Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds
US6887870B1 (en) * 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
WO2007014851A2 (en) * 2005-07-29 2007-02-08 F. Hoffmann-La Roche Ag Indol-3-yl-carbonyl-piperidin and piperazin derivatives
FR2925902B1 (fr) * 2008-01-02 2011-01-07 Sanofi Aventis DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2010080357A1 (en) * 2008-12-18 2010-07-15 Boehringer Ingelheim International Gmbh Serotonin 5-ht2b receptor inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0197840A1 (fr) * 1985-03-26 1986-10-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) (Imidazolyl-4) piperidines, leur préparation et leur application en thérapeutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210080A (ja) * 1985-03-13 1986-09-18 Chisso Corp アルデヒドラクトンの製造法
US5008390A (en) * 1985-05-23 1991-04-16 Smithkline Beckman Corporation Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
US4925851A (en) * 1989-05-23 1990-05-15 Sandoz Pharmaceuticals Corp. 2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0197840A1 (fr) * 1985-03-26 1986-10-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) (Imidazolyl-4) piperidines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
NZ248776A (en) 1995-09-26
HUT65303A (en) 1994-05-02
MA22981A1 (fr) 1994-04-01
PL172860B1 (pl) 1997-12-31
OA09840A (fr) 1994-08-15
CN1087339A (zh) 1994-06-01
MX9305932A (es) 1994-04-29
IL107133A (en) 1998-03-10
NO933435D0 (no) 1993-09-27
NO933435L (no) 1994-03-29
PL300515A1 (en) 1994-04-05
HU9302727D0 (en) 1993-12-28
CZ282080B6 (cs) 1997-05-14
DZ1718A1 (fr) 2002-02-17
IL107133A0 (en) 1993-12-28
KR940007020A (ko) 1994-04-26
FI934221A (fi) 1994-03-29
FI934221A0 (fi) 1993-09-27
TNSN93107A1 (fr) 1994-03-17
CA2107061A1 (en) 1994-03-29
HU211249A9 (en) 1995-11-28
JPH06211838A (ja) 1994-08-02
AU4860693A (en) 1994-04-14
SK103193A3 (en) 1994-08-10
CZ9302015A3 (en) 1994-04-13
US5434169A (en) 1995-07-18
FR2696177A1 (fr) 1994-04-01
EP0591027A1 (fr) 1994-04-06
FR2696177B1 (fr) 1995-05-12
AU658533B2 (en) 1995-04-13
ZA937156B (en) 1994-05-23
AP9300575A0 (en) 1993-10-31
TW272190B (hu) 1996-03-11

Similar Documents

Publication Publication Date Title
KR101766502B1 (ko) 인돌 화합물 및 그의 의약 용도
US5712270A (en) 2-arylamidothiazole derivatives with CNS activity
JP3315970B2 (ja) ニューロキニンアンタゴニストとしてのピペラジノ誘導体
WO2014137723A1 (en) Compounds inhibiting leucine-rich repeat kinase enzyme activity
AP424A (en) Piperidine derivatives, their preparation and their application in therapy.
CA2428468C (en) New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
JPH08253474A (ja) インドールピペリジン誘導体
EA029097B1 (ru) Совместные кристаллы и соли ингибиторов ccr3
CS100192A3 (en) Piperidine derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives
JPH05504358A (ja) 置換尿素化合物及びそれらの製法及び使用
CN115925699B (zh) 具有镇痛活性的稠环化合物及其制备方法与用途
KR100196969B1 (ko) 축합 디아제피논, 이의 제조방법 및 이를 함유하는 약제학적 조성물
UA82227C2 (uk) 7-азаіндоли та їх застосування як терапевтичних засобів, спосіб їх одержання, лікарський засіб на їх основі
GB2044250A (en) Azepino (1,2,3-m) - carboline compound and processes for preparing the same
PT99280B (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
US5610155A (en) Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation
US20040067959A1 (en) Morphinoid derivatives as delta-opioid agonists and antagonists
FI115301B (fi) Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi
RU2610274C2 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
US20040019070A1 (en) Pyrrole-condensed morphinoid derivatives
JP3029870B2 (ja) キノリン誘導体
JPH05213885A (ja) デカヒドロキノリンの新規な誘導体、それらの製造法、製造中間体、それらの薬剤としての用途及びそれらを含有する組成物
JPH07118249A (ja) 新規フェノキシアルキルピペラジン誘導体